Home / Inspections / 1311796

FDA Inspection 1311796 — UPMC Carlisle

UPMC Carlisle — FEI 2573242

The FDA completed an inspection of UPMC Carlisle on March 5, 2026 in Carlisle, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 5, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Carlisle, PA (United States)

Facility

Other inspections at this facility

  • 1070197 (NAI Thu Sep 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 971867 (NAI Wed May 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 878128 (NAI Fri May 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 783851 (NAI Wed May 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 671886 (NAI Wed Jul 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources